Healthcare is literally of vital importance, and requires understanding of ethical and social as well as financial issues; yet healthcare is in great need of sensible economic policies to achieve value for money. This has always been an area of special interest to Europe Economics.
Our studies have ranged from large-scale empirical research into how policies are working, to short explanations of some fundamental issues; and from published reports to expert court testimony.
The areas studied have included mainstream healthcare services, pharmaceuticals, and social services allied to healthcare. Some examples of the issues on which we have advised are:
Our clients are both public sector policy-making organisations, and private sector companies and trade associations. They have included the UK Department of Health, the Portuguese pharmaceuticals regulator, the European Commission (DG Enterprise), the General Chiropractic Council, the General Optical Council, the General Dental Council, Ranbaxy, EFPIA, Merck, Pfizer, GSK, AstraZeneca and other leading manufacturers.
Our in-house team in this field includes: Dermot Glynn, Andrew Lilico, Stephen Topping, Iona McCall, Ross Dawkins and Deborah Drury.